A study, published in Lancet Psychiatry, looked at cannabidiol (CBD) in treating people with cannabis use disorder. Prof Sir … read more
The dangers of illegal drugs are well known and rarely disputed, but how harmful are alcohol and tobacco by comparison? … read more
A case study, published in the European Respiratory Journal, reports on an individual who developed a lung disease following use … read more
A study, published in The Lancet Psychiatry, reports that there is currently insufficient good quality evidence to support the use of cannabinoids … read more
The National Institute for Health and Care Excellence (NICE), has released draft guidance on the use of cannabidiol based medications for … read more
Research, published in JAMA Pediatrics, reports that adolescents who have a history of using e-cigarettes are more likely to use … read more
NHS England have published a review called ‘Barriers to accessing cannabis-based products for medicinal use on NHS prescription’± , and … read more
At a meeting from July 22nd-25th, the European Medicines Agency (EMA) granted positive approval for the use of Epidyolex (cannabidiol) … read more
The House of Commons Health and Social Care Committee has published a report on medicinal cannabis use in the UK. … read more
Reactions to an opinion piece published in the BMJ on the availability of medical cannabis in the UK. Dr Tom … read more
Research published in Lancet Psychiatry demonstrates that daily use of high potency cannabis is linked to higher rates of psychosis. … read more
Many countries have legalised or decriminalised cannabis use, leading to concerns that this might result in an increase in recreational … read more
Reactions to a meta-analysis published in JAMA Psychiatry which demonstrates a correlation between cannabis use and depression/anxiety in young people. … read more
Cannabis is the most commonly used recreational drug by teenagers worldwide and while there has been a lot of focus … read more
Reactions to research published in Human Reproduction that states men who had ever smoked marijuana had high sperm concentration and … read more
Research published in Journal of Neuroscience presents evidence suggesting structural brain and cognitive effects in adolescents following one or two … read more
The home secretary has written to the chair of the Advisory Council on the Misuse of Drugs about scheduling of cannabis-derived medicinal products. read more
The Advisory Council on the Misuse of Drugs (ACMD) has written to the Home Office detailing their short-term advice on the scheduling of cannabis-derived medicinal products.
Prof Dame Sally Davies, Chief Medical Officer for England and Chief Medical Adviser to the UK government, has reviewed evidence for the therapeutic benefit of cannabis-based medicinal products. read more
The case of Billy Caldwell has grabbed the attention of the country as debates have raged around whether cannabis should be legalised, if cannabis products should be available on the NHS, who should have the final say on medical matters and whether the UK has the right approach to illegal drugs. A lot of this debate assumes that cannabis and its products have an important role in modern medicine, and epilepsy in particular, but the science is not that straightforward.
